Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record with results posted

A Phase 1, Randomized, Open Label, Crossover Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of QEV-817 Oral Suspension in Healthy Volunteers

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06585163
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-08-06T00:04:38.614020+00:00
Published At
2026-08-05T00:00:00+00:00
Record Updated At
2026-08-05
Results Posted At
2026-08-05
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Healthy", "PK Drug-drug Interaction Study"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-08-05"
protocolSection.identificationModule.nctId
"NCT06585163"
protocolSection.identificationModule.officialTitle
"A Phase 1, Randomized, Open Label, Crossover Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of QEV-817 Oral Suspension in Healthy Volunteers"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2026-08-05"

Study condition terms

  • Healthy (protocolSection.conditionsModule.conditions)
  • PK Drug-drug Interaction Study (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.